ClinicalTrials.gov
public full text
Public Domain
Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.
The purpose of this research study is to collect samples of blood and stool and analyse primary tumor from participants with breast cancer to see how the bacteria in the body affect cancer and how well it responds to treatment. By comparing samples and data from multiple participants with breast cancer, it may be possible to identify how a person's gut health and tumor microenvironment affects how they respond to certain cancer treatments.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers.#330791
- Intestine Bacteria and Breast Cancer Risk#861556
- the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer#904584
- Clinical potential of the gut microbiome in oncology: a scoping review of treatment response, toxicity and biomarker development.#301599
- Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics#1008216
Record · ID 1087512
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive